HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Integrins

A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors(RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.
Networked: 3019 relevant articles (40 outcomes, 325 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Tang, Chih-Hsin: 18 articles (06/2014 - 01/2004)
2. Goodman, Simon L: 13 articles (10/2015 - 06/2009)
3. Ginsberg, Mark H: 12 articles (07/2015 - 08/2002)
4. Chen, Xiaoyuan: 12 articles (01/2013 - 01/2004)
5. Hynes, Richard O: 11 articles (02/2015 - 01/2002)
6. Okada, Yuji: 11 articles (01/2008 - 01/2003)
7. Funahashi, Hitoshi: 11 articles (01/2008 - 01/2003)
8. Sawai, Hirozumi: 11 articles (01/2008 - 01/2003)
9. Manabe, Tadao: 11 articles (01/2008 - 01/2003)
10. Languino, Lucia R: 10 articles (02/2015 - 08/2005)

Related Diseases

1. Neoplasms (Cancer)
2. Glioma (Gliomas)
3. Infection
4. Multiple Sclerosis
5. Prostatic Neoplasms (Prostate Cancer)

Related Drugs and Biologics

1. Ligands
2. arginyl-glycyl-aspartic acid
3. Collagen
4. Peptides
5. Fibronectins (Fibronectin)
6. Cilengitide
7. Antigens
8. Integrin alphaVbeta3
9. EMD 121974
10. Monoclonal Antibodies

Related Therapies and Procedures

1. Therapeutics
2. Castration
3. Immunotherapy
4. Transplantation (Transplant Recipients)
5. Heterologous Transplantation (Xenotransplantation)